
Regeneron's Livsayis (cemdisiran) gains FDA approval for adults with antibody-positive generalized myasthenia gravis, dosed four times a year.
May 2004 Table of Contents
over 22 years ago
The Risk Management Mandateover 22 years ago
Partners in Learningover 22 years ago
Early Warnings





